UK Markets closed

Ultimovacs ASA – New share capital registered

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Oslo, Norway, 2 November 2021

Reference is made to the stock exchange announcement published by Ultimovacs ASA (the "Company") on 27 October 2021 regarding the successful placing of a private placement with gross proceeds of NOK 270 million (the "Private Placement").

The share capital increase related to Private Placement has been registered with the Norwegian Register of Business Enterprises. Following such registration, the share capital of the Company is NOK 3,422,176.10 divided into 34,221,761 shares, each with a par value of NOK 0.10.

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

For additional information, please contact:

Carlos de Sousa, Chief Executive Officer
Email: carlos.desousa@ultimovacs.com
Phone: +47 908 92 507

Hans Vassgård Eid, Chief Financial Officer
Email: hans.eid@ultimovacs.com
Phone: +47 482 48 632



Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting